The World Market for Immunoassays

Published: November 6, 2013 | Price: $3,995.00 – $7,990.00

The World Market for Immunoassays Visit our Immunoassays curated page for complete industry coverage. The immunoassay market is large and long-established, but at the same time highly competitive. Kalorama Information’s newly published report, The World Market for Immunoassays, describes the opportunities that exist for large IVD companies adopting new strategies and for new entrants to take market share. Immunoassays have been used in clinical laboratory medicine since the 1960s, and are indispensable tools in clinical diagnostics. A wide range of...

The World Market for Infectious Disease Diagnostic Tests

Published: October 21, 2013 | Price: $3,995.00 – $7,990.00

Infectious diseases are among the most challenging issues facing health care delivery systems around the world today. The World Health Organisation estimates that more than 17 million people die of an infectious disease each year, with many of these acquired in hospitals. This Kalorama Information report, The World Market for Infectious Disease Diagnostic Tests, takes a comprehensive look at the markets for companies of testing products that can combat infectious disease threats. One of the Most Dynamic Areas of the...

The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition

Published: September 22, 2013 | Price: $2,995.00 – $6,000.00

The World Market for Biosimlars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition This study, The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others), is designed to provide a comprehensive look at the various strategies being used by select worldwide generic companies in exploring the emerging area of biosimilars, the issues and trends that are shaping the marketplace, and the potential feasibility of providing biosimilars within the United States regulatory environment....

Medical Device Tax: Will There Be a R&D Effect?

Published: September 13, 2013 | Price: $50.00 – $100.00

The medical device tax that took effect Jan. 1, 2013 for all manufacturers of Class I, Class II and Class III devices in the United States may have had an impact on device company spending, according to this complimentary Public Policy Paper from Kalorama Information.  While the tax was in effect in the 2012 year, the paper looks at budgeted R&D spending as companies anticipated new costs from the program. The conclusions are the result of information from Kalorama Information's...

The World Market for Cloud Computing in Healthcare (Saas, IaaS, PaaS, Other Cloud Markets, Healthcare IT Spending and Other Trends)

Published: September 10, 2013 | Price: $995.00 – $1,990.00

The World Market for Cloud Computing in Healthcare Healthcare providers around the world are facing rising costs while they attempt to maintain or improve care. Healthcare information technology (HIT) is a key component of streamlining healthcare in a way that can provide benefits to those involved. As this report details, cloud computing is a way of using existing technology to modernize the healthcare industry. Cloud technologies are generally off-site, third-party-managed computing resources that can include computational resources, additional data storage...

The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry

Published: August 16, 2013 | Price: $995.00 – $1,995.00

The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry The "Patient Protection and Affordable Care Act" (H.R. 3590) is complex legislation that affects virtually every aspect of health care, and many of its provisions are beginning to take effect now.  IVD manufacturers who have different needs and strategies are now considering the legislation and whether it will help or hurt business plans. The legislation contains a range of different provisions and while the law in a broad sense...

The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment)

Published: August 9, 2013 | Price: $3,995.00 – $7,990.00

This  Kalorama Information report  The Market for Hospital-Acquired Infection Control (Sterilization, Cleaning, Testing, Treatment) focuses on the market for preventing, testing and treating infections in the healthcare environment. Given the cost of hospital-acquired and healthcare-associated infections (HAIs), demand has increased for solutions that can help the healthcare industry reduce infections and the costs associated with them. The U.S. Centers for Disease Control and Prevention (CDC) estimates that around 1 in 20 or 5% of hospitalized patients will contract an HAI.  ...

IVD in China

Published: August 5, 2013 | Price: $2,500.00 – $5,000.00

This report, IVD in China represents Kalorama's complete analysis on the Chinese IVD market.  The report provides an introduction to the healthcare system in China, the results of recent reform efforts, and issues and trends.  Regional breakouts of the Chinese system are provided.  The report describes the role that out-of-pocket expenditures and private concerns play in the delivery of healthcare in the nation. The modern Chinese healthcare market was borne of and continues to be guided by the progressive intentions...

Next Generation Sequencing Trends (Clinical Applications, Systems Used, Accreditation Status, Regulated Patient Sample Handling and Other Trends)

Published: July 1, 2013 | Price: $1,500.00 – $3,000.00

Next Generation Sequencing Trends (Clinical Applications, Systems Used, Accreditation Status, Regulated Patient Sample Handling and Other Trends) Next-generation sequencing is discussed frequently as a key to clinical diagnostics in the future. This report looks at the status of NGS today, and seeks to provide insights on the “on-the-ground” status of clinical sequencing. In the course of doing this, the report seeks to answer the following questions: What is the status of clinical applications for Next Gen in laboratories currently? What...

The World Market for Cardiovascular Diagnostics (Markets for ECG, Imaging, Cardiac POC, Contrast Agents and Cardiac Markers)

Published: June 25, 2013 | Price: $3,995.00 – $7,990.00

This report, The World Market for Cardiovascular Diagnostics, provides the reader with an overview of the global cardiac diagnostics industry and the trends driving growth. Segments within the cardiac diagnostic market include: Electrocardiography including ECG testing, stress testing, Holter monitoring, event monitoring and implantable loop. Cardiac imaging including non-invasive X-Ray, MRI, CT, ultrasound, and nuclear cardiography; and invasive /cardiac catheterization/angiography, intravascular ultrasound, optical coherence technology and electrophysiology. Cardiac point-of-care including cholesterol testing and coagulation testing Cardiac markers Cardiac contrast agents...

The World Market for Orphan Drugs (Markets for Oncology, Hematology, Neurology, Endocrine, Metabolic and Other Drugs)

Published: June 13, 2013 | Price: $2,500.00 – $5,000.00

In recent years, there has been a substantial increase in the number of drugs available to treat rare ("orphan") diseases. This comprehensive report, The World Market for Orphan Drugs, looks at this trend and provides estimates for the market opportunity in the U.S., Europe, Japan and globally. With over 400 pages of market analysis and over 120 figures and tables, the report provides in-depth coverage of key competitors and important trends and challenges for makers of orphan drug treatments. Osteoporosis,...

Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products

Published: May 23, 2013 | Price: $3,500.00 – $7,000.00

The global blood industry has experienced strong growth in recent years and although this brisk expansion will slow somewhat as products continue to mature and pricing pressures increase, growth will remain solid though 2017 as a result of aging populations in the U.S., Europe and Japan; ongoing technology advancements/new product introductions and indications; expansion of health coverage in the U.S. via health care reform; and continued strong promotion of blood donation by collection agencies. Kalorama Information's Blood: The Worldwide Market...

The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives

Published: May 8, 2013 | Price: $2,995.00 – $6,750.00

The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis, therapy selection, therapy monitoring and early detection of cancer recurrence. The market for cancer testing are comprehensively covered in Kalorama Information's Worldwide Market for Cancer Diagnostics, 5th. Edition. This report, authored by Kalorama Diagnostic Analyst Shara Rosen, contains detailed market data on the following IVD segments for...

Advanced Remote Patient Monitoring Systems, 6th Edition

Published: March 28, 2013 | Price: $995.00 – $7,990.00

Patient monitoring systems with advanced features, especially wireless or remote capability, are among the fastest-growing medical devices. The aging population and the associated increases in diseases such as congestive heart disease and diabetes as well as the cost of treating those conditions, is driving sales of these devices. Use of new patient monitoring technologies can result in a need for fewer personnel, increased coverage by existing personnel, and a reduction in errors and are expected to lead to better patient...

Lab Automation Markets, 3rd. Edition (Systems, Key Companies, Forecasts and Trends)

Published: February 23, 2013 | Price: $3,995.00 – $7,990.00

This report, Lab Automation Markets, 3rd Edition, (Systems, Key Companies, Forecasts and Trends), represents Kalorama Information's latest study of the market for systems that enable labs to store, identify and transport large quantities of specimens.  The report analyzes the current and potential world markets for medical laboratory automation systems and equipment - both for clinical diagnostics and drug discovery research laboratories. Many clinical laboratories are facing a number of issues that are challenging their ability to remain competitive. These challenges...

The World Market for Sutures, Staplers and Sealants

Published: January 31, 2013 | Price: $995.00 – $1,990.00

The World Market for Sutures, Staplers and Sealants This Kalorama Information report, The World Market for Sutures, Staplers and Sealants, takes a deep look at these critical products for wound closure and management. The report identifies market size and forecasts the market for the following: Sutures Staplers Sealants For each of these markets, the report contains a breakout of revenues by region including: United States, Europe and Rest of World. The report also contains product discussion and competitive analysis for...

Food Safety Diagnostics, The World Market

Published: January 20, 2013 | Price: $2,500.00 – $5,000.00

The food supply worldwide is under constant threat and effective test products that can ensure food safety are in demand. Microbial pathogens (primarily bacteria), viruses, environmental toxins, food allergens and adulterants, residues of drugs and agricultural chemicals can harm consumers if unchecked. In some countries, testing for Genetically Modified Organisms (GMOs) is also conducted to ensure food authenticity. According to Kalorama Information's Food Safety Diagnostics, The World Market, authored by Emil Salazar, there is an opportunity for IVD companies to...

The U.S. Market for Rx to OTC Switches, 6th Edition

Published: January 11, 2013 | Price: $3,995.00 – $7,990.00

The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as over-the-counter products, once only available by prescription.   This report represents the six time that Kalorama Information has analyzed the market for drugs with switched ingredients in detail.  The market is fueled by several factors including an aging population; steady to increased incidences of conditions and diseases; new drug classes switched to OTC; product demand; economic conditions and several other...

The Global Orthopedic Trauma Device Market (Screws and Plates, IM Fixation, Hip Fixation, Craniofacial and Other)

Published: December 14, 2012 | Price: $1,995.00 – $4,000.00

Fixation systems used to speed healing of trauma injuries represent one of the growth areas of the global orthopedic devices market, with a host of competitors and continual product innovation.  In the United States each year alone, trauma accounts for over 42 million emergency room visits. As the global elderly population grows, so does the incidence of falls and osteoporosis, increasing the need for orthopedic trauma devices. But it is not without its challenges. The report’s geographic scope is worldwide with...

The Next Wave In Cancer Treatment – Kinase Inhibitors

Published: December 4, 2012 | Price: $500.00 – $1,000.00

This Kalorama Information report – The Next Wave in Cancer Treatment--Kinase Inhibitors - is focused on a growing area of cancer treatment, kinase inhibitors. Several cancers are being treated with these newer therapies, which provide a focus of cancer profiled in this report, including: Breast Colorectal Head/Neck Kidney Leukemia Liver Lung Melanoma Ovarian Pancreatic Prostate Stomach The report covers both currently marketed and late stage development kinase inhibitors for cancer treatment. Revenues for this market segment were generated using dollar...

Hernia Repair Device Markets and Procedures

Published: November 6, 2012 | Price: $995.00 – $1,990.00

The hernia repair product market consists of products such as mesh materials, devices including fixation, equipment such as endoscopes, and instruments such as hand tools. The market has experienced steady demand and hernia repair procedures are consistent from year to year. This report, Hernia Repair Device Markets and Procedures looks at the hernia repair industry segment. New product innovation, a steady demand for superior products by surgeons, and increasing procedure volumes will likely fuel growth over the next five years....

The World Market for Stents (Drug-Eluting and Bare Metal Product Markets in US, EU, Japan, India, China and ROW)

Published: October 26, 2012 | Price: $3,995.00 – $7,990.00

The coronary stents industry is a highly competitive one in which innovation occurs rapidly and the technology landscape evolves at a fast pace. As the global population is aging and has a longer life expectancy, the prevalence of coronary heart disease and co-morbid conditions such as hypertension, diabetes and obesity is projected to rise and stimulate the demand for coronary stents. Additionally, a growing acceptance of drug-eluting stents as a more effective treatment for coronary heart disease, along with increasing...

EMR in Europe

Published: October 15, 2012 | Price: $995.00 – $1,990.00

EMR in Europe This report, EMR Europe 2012 is a look at the market and trends impacting electronic medical record software and related services in Europe. Included in the report are statistics influencing the industry, demographics, and company strategies. A market summary includes a total market analysis. Also included is a snapshot look at individual countries’ demographics, healthcare spending, EMR adoption depth and competitive opportunities. Electronic Medical Records has been established in several European countries for the last decade or...